| abstract |
The present invention relates to a therapeutic agent for chronic hepatitis B containing lactoferrin as an active ingredient; a therapeutic agent for chronic hepatitis B containing a mixture of lactoferrin, probiotic and prebiotic as an active ingredient; Use of lactoferrin for use; use of a mixture of lactoferrin, probiotics and probiotics for the manufacture of a therapeutic agent for chronic hepatitis B; a method of treating chronic hepatitis B comprising administration of lactoferrin; and lactoferrin, probiotics and It relates to a method for the treatment of chronic hepatitis B comprising the administration of a mixture of prebiotics. Such a therapeutic agent for chronic hepatitis B is economical and has no side effects, and can be effectively used in the fields of pharmaceuticals and foods and drinks. |